Manward Press

Tesla's down 40% while Elon chases SpaceX billions. Meanwhile, this EV maker just became the world's largest seller...

Dump Tesla for BYD: Why Chinese EV Stock is Better Tesla's down 40% while Elon chases SpaceX billions. Meanwhile, this EV maker just became the world's largest seller...

Shah Gilani explains why investors should consider raising stops and taking profits despite record highs, as markets transition from "buy the rumor" to "sell the news."

Market Strategy: Why It's Time for Caution Despite S&P 500 Records Shah Gilani explains why investors should consider raising stops and taking profits despite record highs, as markets transition from "buy the rumor" to "sell the news."

MicroStrategy holders think they're getting smart Bitcoin exposure. Instead, they're getting fleeced... Shah Gilani reveals a smarter Bitcoin treasury play that doesn't punish you with premiums.

GameStop (GME) vs. MicroStrategy (MSTR): The Smart Bitcoin Treasury Play MicroStrategy holders think they're getting smart Bitcoin exposure. Instead, they're getting fleeced... Shah Gilani reveals a smarter Bitcoin treasury play that doesn't punish you with premiums.

Senate GENIUS Act creates regulatory framework allowing Wall Street institutions to enter $1.6 trillion stablecoin market safely.

GENIUS Act Regulatory Clarity Opens Wall Street to Stablecoin Investment Senate GENIUS Act creates regulatory framework allowing Wall Street institutions to enter $1.6 trillion stablecoin market safely.

Novo Nordisk's 50% decline creates a contrarian buying opportunity. Analysis shows $326B pharma giant trading at $18 forward P/E with 60% upside potential.

Novo Nordisk (NOVO): Why 50% Drop Creates Buying Opportunity Novo Nordisk's 50% decline creates a contrarian buying opportunity. Analysis shows $326B pharma giant trading at $18 forward P/E with 60% upside potential.